Biotech IPO raises hopes for SoftBank Vision Fund rebound

TOKYO — SoftBank Group-backed U.S. biotech startup Relay Therapeutics gained 75% on its trading debut on Nasdaq, raising hopes for a recovery in the performance of Softbank’s $100 billion Vision …
( read original story …)